Williams Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.
|
31418010 |
2019 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Among 110 SNPs within the 7q11.23 WS chromosomal region, we found one associated locus (p = 5e-5) located at GTF2IRD1, which has been implicated in animal models of WS.
|
29884845 |
2018 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
The social phenotype of WBS has been linked to <i>GTF2I</i> or general transcription factor IIi (<i>TFII-I</i>).
|
29568691 |
2018 |
Williams Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The GTF2I and GTF2IRD1 genes encoding the TFII-I family of transcription factors are prime candidates for the Williams-Beuren syndrome, a complex multisystem disorder characterized by craniofacial, skeletal, and neurocognitive deficiencies.
|
28085512 |
2018 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
All patients received 3.7- to 5.5-GBq radioactive iodine (RAI) ablation, post-therapy whole-body scans (TxWBSs), and diagnostic WBS (DxWBSs) during follow-up.
|
27572060 |
2017 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter.
|
27239038 |
2016 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Objectives : GTF2I and GTF2IRD1 genes located in Williams-Beuren syndrome (WBS) critical region encode TFII-I family transcription factors.
|
23145914 |
2013 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
The GTF gene family of transcription factors (GTF2I, GTF2IRD1 and GTF2IRD2) are all highly expressed in the brain, and GTF2I and GTF2IRD1 are involved in the pathogenesis of the cognitive and behavioural phenotypes associated with WBS.
|
23118870 |
2012 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
MGD |
Our study strongly supports a role for GTF2IRD1 in the motoric and anxiety-related abnormalities seen in Williams-Beuren syndrome, and suggests basal ganglia and potentially cerebellar abnormalities in Gtf2ird1 mice.
|
22652393 |
2012 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
MGD |
These data provide new mechanistic insight into the clinical genetic findings in WBS patients and indicate that insufficiency of GTF2IRD1 protein contributes to abnormalities of facial development, motor function and specific behavioural disorders that accompany this disease.
|
22198572 |
2012 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Detailed analyses of homozygous null Gtf2ird1 mice have revealed a series of phenotypes that share some intriguing parallels with WBS.
|
22198572 |
2012 |
Williams Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
De novo CNVs of known pathogenic significance in other genomic disorders were also observed, including deletion at the TAR (thrombocytopenia absent radius) region on 1q21.1 and duplication at the WBS (Williams-Beuren syndrome) region at 7q11.23.
|
22083728 |
2012 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
GTF2IRD2 belongs to a family of transcriptional regulators (including TFII-I and GTF2IRD1) that are responsible for many of the key features of Williams-Beuren syndrome (WBS).
|
22899722 |
2012 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Genes lying telomeric to RFC2, including CLIP2, GTF2I and GTF2IRD1, are currently thought to be the most likely major contributors to the typical Williams syndrome cognitive profile, characterized by a better-than-expected auditory rote-memory ability, a relative sparing of language capabilities, and a severe visual-spatial constructive impairment.
|
22608712 |
2012 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
CTD_human |
This autoregulatory mechanism leads to dosage compensation of GTF2IRD1 transcription in WBS patients.
|
20007321 |
2010 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Along with previously reported cases, clinical-molecular correlations in these two families further confirm that the functional hemizygosity for the GTF2I and GTF2IRD1 genes is the main cause of the neurocognitive profile and some aspects of the gestalt phenotype of WBS.
|
19897463 |
2010 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
The existing mouse models certainly seem to implicate hemizygosity for ELN, BAZ1B, CLIP2, and GTF2IRD1 in WS, and new mice with large deletions of the WS region are helping us to understand both the additive and potential combinatorial effects of hemizygosity for specific genes.
|
20425782 |
2010 |
Williams Syndrome
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
This autoregulatory mechanism leads to dosage compensation of GTF2IRD1 transcription in WBS patients.
|
20007321 |
2010 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
These results combine with previous data from small deletions to suggest the gene GTF2IRD1 is associated with WS facies and VSC, and that GTF2I may contribute to WS social behaviors including increased gaze and attention to strangers.
|
19205026 |
2009 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Analysis of atypical small and rare chromosomal deletions at 7q11.23 points to TFII-I genes (GTF2I and GTF2IRD1) as the prime candidates responsible for craniofacial and cognitive abnormalities in the Williams-Beuren syndrome.
|
19111598 |
2009 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
MGD |
A subset of Gtf2ird1 and Gtf2i heterozygotes displayed microcephaly, retarded growth, and skeletal and craniofacial defects, therefore showing that haploinsufficiency of TFII-I proteins causes various developmental anomalies that are often associated with WBS.
|
19109438 |
2009 |
Williams Syndrome
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Expression of Gtf2ird1 in these tissues correlates with the manifestation of some of the clinical features of Williams syndrome.
|
17239664 |
2007 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
MGD |
In humans, a rare WBS individual with an atypical deletion, including GTF2IRD1, shows facial dysmorphism and cognitive deficits that differ from those of classic WBS cases.
|
16293761 |
2005 |
Williams Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Gtf2ird1-null mice exhibit phenotypic abnormalities reminiscent of the human microdeletion disorder Williams-Beuren syndrome (WBS); craniofacial imaging reveals abnormalities in both skull and jaws that may arise through misregulation of goosecoid, a downstream target of Gtf2ird1.
|
16293761 |
2005 |
Williams Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Williams syndrome deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on chromosome 7q11.23.
|
12865760 |
2004 |